IGF1R and breast carcinoma: Metformin further inhibits cancer cell proliferation through blockage of the IGF/IGF-1R signaling pathway, as shown in PC-3 prostate cancer cells, MKN1, MKN45, and MKN74 gastric cancer cells, and SKBR3 and BT474 breast cancer cells [25–27].